Animalcare Group Plc (ANCR) - Net Assets
Based on the latest financial reports, Animalcare Group Plc (ANCR) has net assets worth GBX113.25 Million GBX (≈ $13.78K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX163.87 Million ≈ $19.94K USD) and total liabilities (GBX50.62 Million ≈ $6.16K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ANCR asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX113.25 Million |
| % of Total Assets | 69.11% |
| Annual Growth Rate | 17.95% |
| 5-Year Change | 38.88% |
| 10-Year Change | 403.27% |
| Growth Volatility | 58.89 |
Animalcare Group Plc - Net Assets Trend (2000–2024)
This chart illustrates how Animalcare Group Plc's net assets have evolved over time, based on quarterly financial data. Also explore Animalcare Group Plc balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Animalcare Group Plc (2000–2024)
The table below shows the annual net assets of Animalcare Group Plc from 2000 to 2024. For live valuation and market cap data, see Animalcare Group Plc (ANCR) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX113.31 Million ≈ $13.79K |
+45.47% |
| 2023-12-31 | GBX77.89 Million ≈ $9.48K |
-1.38% |
| 2022-12-31 | GBX78.99 Million ≈ $9.61K |
+0.24% |
| 2021-12-31 | GBX78.80 Million ≈ $9.59K |
-3.42% |
| 2020-12-31 | GBX81.59 Million ≈ $9.93K |
-0.36% |
| 2019-12-31 | GBX81.89 Million ≈ $9.96K |
-5.43% |
| 2018-12-31 | GBX86.59 Million ≈ $10.54K |
-3.40% |
| 2017-12-31 | GBX89.64 Million ≈ $10.91K |
+275.94% |
| 2017-06-30 | GBX23.84 Million ≈ $2.90K |
+5.91% |
| 2016-06-30 | GBX22.52 Million ≈ $2.74K |
+7.26% |
| 2015-06-30 | GBX20.99 Million ≈ $2.55K |
+7.91% |
| 2014-06-30 | GBX19.45 Million ≈ $2.37K |
+8.30% |
| 2013-06-30 | GBX17.96 Million ≈ $2.19K |
+6.68% |
| 2012-06-30 | GBX16.84 Million ≈ $2.05K |
+6.64% |
| 2011-06-30 | GBX15.79 Million ≈ $1.92K |
+12.13% |
| 2010-06-30 | GBX14.08 Million ≈ $1.71K |
-8.46% |
| 2009-06-30 | GBX15.38 Million ≈ $1.87K |
+5.03% |
| 2008-06-30 | GBX14.64 Million ≈ $1.78K |
+138.63% |
| 2007-06-30 | GBX6.14 Million ≈ $746.70 |
+5.48% |
| 2006-06-30 | GBX5.82 Million ≈ $707.88 |
+2.34% |
| 2005-06-30 | GBX5.68 Million ≈ $691.70 |
+20.52% |
| 2004-06-30 | GBX4.72 Million ≈ $573.92 |
+8.36% |
| 2003-06-30 | GBX4.35 Million ≈ $529.63 |
+14.61% |
| 2002-06-30 | GBX3.80 Million ≈ $462.11 |
+56.43% |
| 2001-06-30 | GBX2.43 Million ≈ $295.42 |
+22.32% |
| 2000-06-30 | GBX1.99 Million ≈ $241.52 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Animalcare Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4495.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX13.79 Million | 12.17% |
| Other Comprehensive Income | GBX2.09 Million | 1.84% |
| Other Components | GBX149.99 Million | 132.37% |
| Total Equity | GBX113.31 Million | 100.00% |
Animalcare Group Plc Competitors by Market Cap
The table below lists competitors of Animalcare Group Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Atlantis S.A.
WAR:ATS
|
$2.79 Million |
|
MODERN LAND (CHINA) DL-01
F:7PJ
|
$2.79 Million |
|
JPMorgan China Growth & Income PLC
LSE:JCGI
|
$2.80 Million |
|
Cyber Media (India) Limited
NSE:CYBERMEDIA
|
$2.81 Million |
|
Cottonindo Ariesta Tbk PT
JK:KPAS
|
$2.79 Million |
|
NorCom Information Technology GmbH & Co. KGaA
XETRA:NC5A
|
$2.79 Million |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
$2.79 Million |
|
Lyc Healthcare Bhd
KLSE:0075
|
$2.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Animalcare Group Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 77,895,000 to 113,312,000, a change of 35,417,000 (45.5%).
- Net income of 32,217,000 contributed positively to equity growth.
- Dividend payments of 3,019,000 reduced retained earnings.
- New share issuances of 20,053,000 increased equity.
- Other comprehensive income decreased equity by 528,001.
- Other factors decreased equity by 13,305,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX32.22 Million | +28.43% |
| Dividends Paid | GBX3.02 Million | -2.66% |
| Share Issuances | GBX20.05 Million | +17.7% |
| Other Comprehensive Income | GBX-528.00K | -0.47% |
| Other Changes | GBX-13.31 Million | -11.74% |
| Total Change | GBX- | 45.47% |
Book Value vs Market Value Analysis
This analysis compares Animalcare Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 181.28x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3514.63x to 181.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | GBX0.09 | GBX332.50 | x |
| 2006-06-30 | GBX0.10 | GBX332.50 | x |
| 2007-06-30 | GBX0.10 | GBX332.50 | x |
| 2008-06-30 | GBX0.24 | GBX332.50 | x |
| 2009-06-30 | GBX0.26 | GBX332.50 | x |
| 2010-06-30 | GBX0.23 | GBX332.50 | x |
| 2011-06-30 | GBX0.26 | GBX332.50 | x |
| 2012-06-30 | GBX0.28 | GBX332.50 | x |
| 2013-06-30 | GBX0.30 | GBX332.50 | x |
| 2014-06-30 | GBX0.32 | GBX332.50 | x |
| 2015-06-30 | GBX0.35 | GBX332.50 | x |
| 2016-06-30 | GBX0.37 | GBX332.50 | x |
| 2017-06-30 | GBX0.40 | GBX332.50 | x |
| 2017-12-31 | GBX1.49 | GBX332.50 | x |
| 2018-12-31 | GBX1.44 | GBX332.50 | x |
| 2019-12-31 | GBX1.36 | GBX332.50 | x |
| 2020-12-31 | GBX1.36 | GBX332.50 | x |
| 2021-12-31 | GBX1.31 | GBX332.50 | x |
| 2022-12-31 | GBX1.30 | GBX332.50 | x |
| 2023-12-31 | GBX1.28 | GBX332.50 | x |
| 2024-12-31 | GBX1.83 | GBX332.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Animalcare Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 28.43%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 43.40%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.40x
- Recent ROE (28.43%) is above the historical average (6.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 4.93% | 3.71% | 1.12x | 1.18x | GBX-288.50K |
| 2006 | 3.49% | 2.59% | 1.01x | 1.34x | GBX-378.80K |
| 2007 | 4.07% | 3.01% | 1.10x | 1.23x | GBX-363.70K |
| 2008 | 6.10% | 7.60% | 0.47x | 1.70x | GBX-571.50K |
| 2009 | 6.75% | 5.89% | 0.70x | 1.65x | GBX-499.20K |
| 2010 | -7.32% | -9.19% | 0.49x | 1.64x | GBX-2.44 Million |
| 2011 | 14.73% | 19.66% | 0.63x | 1.19x | GBX746.10K |
| 2012 | 10.27% | 15.93% | 0.56x | 1.16x | GBX45.30K |
| 2013 | 10.49% | 15.56% | 0.56x | 1.20x | GBX88.80K |
| 2014 | 10.99% | 16.59% | 0.57x | 1.16x | GBX191.70K |
| 2015 | 12.07% | 18.72% | 0.55x | 1.17x | GBX434.90K |
| 2016 | 11.70% | 17.92% | 0.55x | 1.19x | GBX382.50K |
| 2017 | 10.36% | 15.57% | 0.55x | 1.21x | GBX85.50K |
| 2017 | 0.21% | 0.30% | 0.41x | 1.69x | GBX-8.78 Million |
| 2018 | -0.26% | -0.31% | 0.50x | 1.66x | GBX-8.88 Million |
| 2019 | -1.63% | -1.88% | 0.55x | 1.57x | GBX-9.53 Million |
| 2020 | 0.29% | 0.33% | 0.57x | 1.53x | GBX-7.93 Million |
| 2021 | -0.10% | -0.10% | 0.67x | 1.40x | GBX-7.96 Million |
| 2022 | 2.49% | 2.74% | 0.61x | 1.50x | GBX-5.93 Million |
| 2023 | 1.54% | 1.61% | 0.70x | 1.37x | GBX-6.59 Million |
| 2024 | 28.43% | 43.40% | 0.47x | 1.40x | GBX20.89 Million |
Industry Comparison
This section compares Animalcare Group Plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,848,892,964
- Average return on equity (ROE) among peers: -65.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Animalcare Group Plc (ANCR) | GBX113.25 Million | 4.93% | 0.45x | $2.79 Million |
| Allergy Therapeutics (AGY) | $48.53 Million | 5.95% | 0.81x | $7.66 Million |
| Alliance Pharma plc (APH) | $2.24 Million | -3.15% | 0.01x | $4.26 Million |
| Celadon Pharmaceuticals PLC (CEL) | $3.18 Million | -224.46% | 1.90x | $112.25K |
| Chill Brands Group PLC (CHLL) | $2.11 Million | -387.19% | 0.58x | $25.45K |
| Eco Animal Health Group Plc (EAH) | $5.52 Million | 11.11% | 0.20x | $763.17K |
| HUTCHMED China Ltd (HCM) | $84.43 Million | -21.03% | 0.40x | $20.39 Million |
| Hikma Pharmaceuticals PLC (HIK) | $48.03 Million | 21.86% | 0.98x | $37.94 Million |
| Haleon PLC (HLN) | $16.46 Billion | 6.44% | 1.12x | $372.86 Million |
| Indivior PLC (INDV) | $-11.00 Million | 0.00% | 0.00x | $18.79 Million |
About Animalcare Group Plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company operates in Belgium, the Netherlands, the Unite… Read more